Neoadjuvant therapy with lapatinib or trastuzumab for early breast cancer

Bookmark and Share
Published: 18 Jan 2011
Views: 5006
Prof Michael Untch - Helios Clinic, Berlin, Germany
Researchers presented Phase III efficacy data from the GeparQuinto study, a head-to-head comparison of neoadjuvant lapatinib and trastuzumab in combination with chemotherapy for patients with early breast cancer, at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12 2010.